The Trump administration’s new deal to provide uninsured Americans with free drugs to prevent HIV infection could be a promising step, but actually reaching the very people most in need -- and convincing them to take it -- will be…
By Jason Kane
Sunday marked World Tuberculosis Day. While T.B. doesn’t attract the same attention as influenza, malaria or Ebola, it recently surpassed HIV/AIDS to become the globe's leading infectious killer. In 2018, there were more than 10 million new cases. There hadn’t…
Russia, Nigeria and Florida are three of the regions hardest hit by the HIV/AIDS crisis. The PBS NewsHour will be joined on Twitter on June 26 at 1 p.m. EDT to discuss why the AIDS epidemic continues to cripple these…
By Lora Strum
Here is a look at efforts that are exploring new treatments or trying to lift the stigma around HIV and AIDS.
By Larisa Epatko
By Heather Boerner
NIH officials have announced that after 2020, they don’t plan to fund topical HIV prevention products like douches or gels, unless they can protect the whole body, or unless early studies have shown they can substantially reduce HIV risk.
It’s a bold mission by any standard: to end the AIDS epidemic. But the tools are there, say officials of the Joint United Nations Program on HIV/AIDS. Watch our six part series on the plan.
By Anne-christine d’Adesky, KQED Future of You
The HIV research community is increasingly optimistic about the “shock and kill” treatment approach, which appears to remove all traces of the virus from an individual’s body.
A new study pinpoints exactly when HIV arrived in the U.S., while also exonerating Gaëtan Dugas, a man once branded as "patient zero" and blamed for starting the outbreak.
By Heather Boerner
New research highlights the vagina as a powerful HIV prevention tool.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.